Make better triage decisions with the biomarker suPAR

suPAR is a prognostic inflammatory biomarker that reflects the level of activation of the human immune system across diseases.

suPAR is measured by ViroGates’ suPARnostic® product range.

A low suPAR level indicates a good prognosis and supports patient discharges.

A high suPAR level indicates the presence, progression, and severity of a disease, organ damage, and risk of mortality, and supports patient hospitalizations.

Improve patient care

Up to 22% reduction in hospital admissions1 and up to 6% reduction in hospital length-of-stay per patient2

Reduce healthcare costs

Up to €100-380 savings per admission depending on medical specialty and geography3